The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; none of the 6 sources its claims cite is checked for support yet.
The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment
Open accessAbstract
The gut microbiota is suspected to promote colorectal cancer (CRC). Escherichia coli are more frequently found in CCR biopsies than in healthy mucosa; furthermore, the majority of mucosa-associated E. coli isolated from CCR harbors the pks genomic island (pks+ E. coli) that is responsible for the synthesis of colibactin, a genotoxic compound. We have recently reported that transient contact of a few malignant cells with colibactin-producing E. coli increases tumor growth in a xenograft mouse model. Growth is sustained by cellular senescence that is accompanied by the production of growth factors. We demonstrated that cellular senescence is a consequence of the pks+ E. coli-induced alteration of p53 SUMOylation, an essential post-translational modification in eukaryotic cells. The underlying mechanisms for this process involve the induction of miR-20a-5p expression, which targets SENP1, a key protein in the regulation of the SUMOylation process. These results are consistent with the expression of SENP1, miR-20a-5p and growth factors that are observed in a CRC mouse model and in human CCR biopsies colonized by pks+ E. coli. Overall, the data reveal a new paradigm for carcinogenesis in which pks+ E. coli infection induces cellular senescence characterized by the production of growth factors that promote the proliferation of uninfected cells and, subsequently, tumor growth.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Colibactin-producing *E. coli* (pks+ *E. coli*) induce cellular senescence in intestinal epithelial cells via a c-Myc/miR-20a-5p/SENP1 axis that increases SUMO-conjugated p53, and the resulting senescence-associated secretory phenotype (notably HGF) promotes proliferation of uninfected cells and tumor growth. The authors propose that pks+ *E. coli* modify the tumor microenvironment to favor colon tumor promotion.
Key findings
- Transient infection of HCT116 xenografts in nude mice at low MOI (20) increased tumor growth and Ki67-positive cells, whereas high MOI (100) decreased tumor growth, consistent with tumor dormancy from massive cell-cycle arrest (n = 5/group; *P* < 0.05).
- Conditioned medium from pks+ *E. coli*-infected cells increased proliferation of uninfected cells to a degree similar to medium with 10% fetal bovine serum; this was reproduced across Int-407, HCT8, Caco-2, HT-29, HCT116 and non-transformed IEC-6 cells.
- pks+ *E. coli* induced senescence (SA-β-gal, phospho-p53, p21^Cip, Rb accumulation, decreased E2F-1) with increased HGF, FGF and GM-CSF; tumors at day 10 post-implantation showed an ~3-fold increase in the percentage of senescent cells versus pks− controls.
- An HGF pathway inhibitor (and neutralizing antibodies) abrogated the pro-proliferative activity of conditioned medium and significantly blocked xenograft growth; mechanistically, pks+ *E. coli* induced c-Myc, which drove miR-20a-5p, which bound the SENP1 3′-UTR and reduced SENP1, increasing SUMO1-conjugated p53.
- In the AOM/DSS model, colonization with a clinical pks+ *E. coli* strain significantly increased colon tumor number versus the isogenic pks mutant, without affecting inflammatory score or tumor size; γH2Ax, miR-20a-5p, SA-β-gal, p21^Cip and HGF pathway activation were increased. Human colon adenocarcinoma biopsies colonized by pks+ *E. coli* showed the same signature (high γH2Ax, miR-20a-5p, senescence markers, HGF mRNA and activated HGF receptors; decreased SENP1-expressing cells), differentiating them from pks−-colonized tumors by redundancy analyses.
Methods
- Xenograft model: HCT116 cells (2 × 10⁶) subcutaneously injected into nude mice and infected for 3 hours with pks+ *E. coli* or isogenic pks− *E. coli* at MOI 20 or 100; tumor size monitored over time.
- In vitro assays: conditioned medium transfer to measure proliferation of uninfected cells across multiple intestinal epithelial lines; SA-β-gal, senescence protein profiles, growth factor expression, SUMOylation patterns, miR-20a-5p/SENP1 reporter and transfection experiments, and inhibitor/neutralizing antibody treatments.
- In vivo validation: AOM/DSS (azoxymethane/dextran sodium sulfate) CRC mouse model colonized with a clinical pks+ *E. coli* strain versus its isogenic pks mutant, plus analysis of human colon adenocarcinoma biopsies colonized by pks+ versus pks− *E. coli* (including redundancy analyses).
Limitations
- Stated: pks+ *E. coli*-induced senescence was also observed in p53−/− cells, suggesting pathways other than p53 signaling may be involved.
- Stated: no increase in tumor size was observed with pks+ *E. coli* in the AOM/DSS model in immunocompetent mice, possibly because senescent tumors generate an immune response that constrains expansion; the authors note the promoting effect on intestinal tumor size may be difficult to observe.
- Stated: the study focused on colibactin as the sole toxin affecting the cell cycle, but clinical pks+ *E. coli* frequently also produce CNF1, whose impact on CRC remains to be explored; overall understanding of the cancer-promoting potential of pks+ *E. coli* remains limited and clinical consequences need clarification.
- Evident from the text: several supporting results are described as "unpublished data" (e.g., high-MOI growth decrease, SUMOylation patterns, anacardic acid and SENP1 overexpression effects), and the role of the dormancy-type interaction in intestinal tumors "remains to be assessed."
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 6 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, using a reporter assay, we demonstrated that miR-20a-5p binds to the SENP1 mRNA 3'-UTR.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“pksC E. coli-infected cells displayed a modified pattern of SUMO-conjugated proteins compared with pks-E.coliinfected cells or uninfected cells (unpublished data).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“pksC E. coli, in contrast to pks-E.coli, induced a time- dependent and dose-dependent increase in SA-b-gal activity.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of note, the expression levels of FGF, GM-CSF and HGF were also increased in xenografts at 10 d post-pksC E. coli infection compared to xenografts infected with pks-E.coli.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: The subcutaneous xenograft model in immunodeficient mice is a valid model for the effect of pksC E. coli on human colon tumor growth.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interestingly, pksC E. coli-infected cells expressed significantly higher levels of the growth factors HGF, FGF, and GM-CSF than pks-E.coli-infected cells.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, transfection of cells with mature miR-20a-5p decreased SENP1 expression at both the mRNA and protein levels.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interestingly, over-expression of SENP1, unlike overexpression of an inactive SENP1, significantly decreased the number of senescent cells induced by pksC E. coli infection, confirming the role of SENP1 in pksC E. coli-induced senescence.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this model, a single and transient exposure of xenografts to pksC E. coli at a multiplicity of infection (MOI) of 20 was associated with an increase in tumor growth and Ki67positive cell numbers, suggesting that pksC E. coli enhance cell proliferation (Fig. 1A).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: The subcutaneous xenograft model in immunodeficient mice is a valid model for the effect of pksC E. coli on human colon tumor growth.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“An HGF pathway inhibitor, in contrast to vehicle or other growth factor inhibitors abrogated the pro-proliferative activity of CM in vitro.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, an anti-miR-20a-5p abrogated pksC E. coli-induced accumulation of SUMO1-conjugated p53 and, consequently, cellular senescence.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 12
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“pksC E. coli did not affect the inflammatory score or the size of the tumors.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The AOM/DSS mouse model is a valid model for human colorectal cancer promotion by pksC E. coli.
In the paper
“pksC E. coli-infected cells exhibited an accumulation of phospho-p53, p21 Cip , and Retinoblastoma protein as well as a decrease in E2F-1 expression at day 5 post-infection, which correspond to a protein expression profile characteristic of senescent cells.12”
What the sources say
- Not checked yetcites [12] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As observed upon pksC E. coli infection, cells transfected with miR-20a-5p produced significant levels of HGF, and their CM induced the proliferation of untransfected cells.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Accordingly, we observed an accumulation of SUMO1-conjugated p53, which is known to drive cellular senescence.17 This accumulation was associated with a decrease in SENP1 expression, a key enzyme involved in the control of the SUMOylation process.17”
What the sources say
- Not checked yetcites [17] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Accordingly, we observed that pksC E. coli infection, which is known to induce DNA damage, 9,10 induced c-Myc expression and its binding to the miR-20a-5p promoter.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, time-course experiments showed that pksC E. coli induced c-Myc expression 3 d after infection, followed by modifications of miR-20a-5p and SENP1 expression levels 2 d later.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Transfection of pksC E. coli-infected cells with c-Myc siRNA strongly reduced the expression of miR20a-5p, increased the expression of SENP1, reduced the level of SUMO-conjugated p53, decreased the number of pksC E. coli-induced senescent cells and consequently abolished the pro-proliferative effect of the CM derived from those cells.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The DNA damage marker gH2Ax, the miR-20a-5p expression level and senescence markers (SA-b-gal activity and p21 cip expression) were significantly increased in tumors isolated from mice colonized by the clinical pksC E. coli strain compared with those isolated from mice colonized by the corresponding isogenic mutant.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The AOM/DSS mouse model is a valid model for human colorectal cancer promotion by pksC E. coli.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As observed in the AOM/DSS mouse model, human biopsies colonized by pksC E. coli harbored high expression levels of gH2Ax, miR-20a-5p, senescence markers (SA-b-gal, p21 cip ), and HGF mRNA and activated HGF receptors, as well as a decrease in the number of SENP1-expressing cells.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“pksC E. coli activate the miR-20a-5p/SENP1/senescence/HGF pathway (Fig. 1B) in human and murine colon adenocarcinomas and therefore may contribute to CCR development.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our findings suggest that colibactin-producing E. coli modulate the tumor microenvironment by inducing the secretion of several growth factors from senescent cells, which can promote tumor growth.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The subcutaneous xenograft model in immunodeficient mice is a valid model for the effect of pksC E. coli on human colon tumor growth.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Consequently, colibactinproducing bacteria can modulate the tumor microenvironment to favor the emergence of senescent cells, which may also affects tumor promotion and cancer progression via the secretion of growth factors.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
The pks genomic island is responsible for the synthesis of colibactin, a genotoxic compound.
“the majority of mucosa-associated E. coli isolated from CCR harbors the pks genomic island (pksC E. coli) that is responsible for the synthesis of colibactin, a genotoxic compound.”
The paper relies on this without support.
The subcutaneous xenograft model in immunodeficient mice is a valid model for the effect of pksC E. coli on human colon tumor growth.
“The promotion of tumor growth was clearly observed in the subcutaneous xenograft model using immunodeficient mice.”
The paper relies on this without support.
The AOM/DSS mouse model is a valid model for human colorectal cancer promotion by pksC E. coli.
“To confirm the reliability of our findings, we explored the impact of a clinical pksC E. coli strain in an AOM/DSS (azoxymethane/dextran sodium sulfate) CRC mouse model.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“in several mouse models, other colibactin-producing E. coli have been observed to promote the development of colorectal cancer [125–131]”
From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [129]
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Four faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells
Nougayrède, J.-P., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., Buchrieser, C., Hacker, J., Dobrindt, U., & Oswald, E. (2006) · Science · doi:10.1126/science.1127059 · Cited by 1,188
The signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046
Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells
Cuevas-Ramos, G., Petit, C. R., Marcq, I., Boury, M., Oswald, E., & Nougayrède, J.-P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001261107 · Cited by 855
Flagged first, then by citations
Research works printed but not linked: 2
- Matsui S, 2010, Int J Oncol, 37, 289
- 10.1016/s0962-8924(01)02151-1 · DOI · Paper page
Cited by
Sorted by citations
Items 201–296 of 296
Mezerová, K., Starý, L., Zbořil, P., Klementa, I., Stašek, M., Špička, P., Skalický, P., & Raclavský, V. (2021) · Life · doi:10.3390/life11111165 · Cited by 9
Small Animals Gut Microbiome and Its Relationship with Cancer
Ferrarias, T. M., & Santos, A. A. F. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95780 · Cited by 7
Zulpa, A. K., Barathan, M., Iyadorai, T., Mariappan, V., Vadivelu, J., Teh, C. S. J., & Vellasamy, K. M. (2023) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-023-03767-1 · Cited by 7
Sadeghi, M., Mestivier, D., Carbonnelle, É., Benamouzig, R., Khazaie, K., & Sobhani, I. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1313735 · Cited by 7
Chiba, N., Suzuki, S., Enríquez, D., Utsunomiya, A., Kubuki, Y., Hidaka, T., Shimoda, K., Nakahata, S., Yamada, T., & Morishita, K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38507 · Cited by 7
Are we any closer to screening for colorectal cancer using microbial markers?A critical review
Starý, L., Mezerová, K., Skalický, P., Zbořil, P., & Raclavský, V. (2017) · Biomedical Papers · doi:10.5507/bp.2017.051 · Cited by 7
The Bethesda system for the reporting of cervical/vaginal cytology
Oren, A., & Fernandes, J. (1991) · The Journal of the American Osteopathic Association · doi:10.1515/jom-1991-900513 · Cited by 7
Pai, Y.-C., Huang, C., Lin, L.-Y., Li, Y.-H., & Yu, L. C. (2025) · Journal of physiological investigation. · doi:10.4103/ejpi.ejpi-d-25-00045 · Cited by 6
Primary tumor microbiomes predict distant metastasis of colorectal cancer
Parajuli, B., Midya, V., Kiddle, R., Jager, N. D., Eggers, S. I., Spakowicz, D. J., Hoyd, R., Salhia, B., Chan, C. H. F., Churchman, M. L., et al. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01188-x · Cited by 7
Ma, G., Li, X., Tao, Q., Ma, S., Du, H., Hu, Q., & Xiao, H. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2352796 · Cited by 6
Immunomodulatory properties of CNF1 toxin from E. coli: implications for colorectal carcinogenesis.
Fabbri, A., & Bracci, L. (2022) · PubMed Central · Cited by 6
Engineering live attenuated vaccines: Old dogs learning new tricks
Plocica, J. A., Guo, F., Das, J. K., Kobayashi, K. S., Ficht, T. A., Alaniz, R. C., Song, J. J., & de Figueiredo, P. (2023) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2023.100198 · Cited by 6
Microbiome and the Hallmarks of Cancer
Bleich, R. M., & Arthur, J. C. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-67951-4_1 · Cited by 8
Nutritional Modulators of Cellular Senescence In Vitro
Provinciali, M., Pierpaoli, E., Piacenza, F., Giacconi, R., Costarelli, L., Basso, A., Recchioni, R., Marcheselli, F., Bray, D. H., Benlhassan, K., et al. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801816-3.00022-4 · Cited by 6
Bacteria in Carcinogenesis and Cancer Prevention: A Review Study
Nokhandani, N., Poursheikhani, A., Alhosseini, M. N., & Davoodi, H. (2021) · International Journal of Cancer Management · doi:10.5812/ijcm.107956 · Cited by 6
Di Pierro, F., Sagheddu, V., Galletti, S., Casaroli, A., Labrini, E., Soldi, S., Cazzaniga, M., Bertuccioli, A., Matera, M., Cavecchia, I., et al. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10522-5 · Cited by 5
Li, J.-X., Liu, C., & Chen, J. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00775-x · Cited by 5
Phenotypic characterization and complete genome of a tumorigenic pathobiont Escherichia coli LI60C3
Yu, L. C., Wei, S., Li, Y.-H., Huang, C., Pai, Y.-C., Hung, Y.-M., Lai, L., & Ni, Y. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00732-1 · Cited by 5
The Microbiome: the Link to Colorectal Cancer and Research Opportunities
Cass, S. H., Ajami, N. J., & White, M. G. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-00960-6 · Cited by 5
Wallenstein, A., Rehm, N., Brinkmann, M., Selle, M., Bossuet‐Greif, N., Sauer, D., Bunk, B., Spröer, C., Wami, H. T., Homburg, S., et al. (2020) · mSphere · doi:10.1128/msphere.00727-20 · Cited by 6
Lei, Y., Shan, Y., Zhou, D., & Chen, C. (2025) · Hereditas · doi:10.1186/s41065-025-00456-x · Cited by 4
Mezerová, K., Raclavský, V., & Starý, L. (2021) · Biomedical Papers · doi:10.5507/bp.2021.054 · Cited by 5
Gut microbes as a therapeutic armory
Bhardwaj, N., & Geva‐Zatorsky, N. (2018) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2019.08.007 · Cited by 4
Special Issue “Bacterial Toxins and Cancer”
Travaglione, S., Carlini, F., Maroccia, Z., & Fabbri, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042128 · Cited by 4
Metabolomics-based analysis of the correlation between lipid metabolites and thyroid carcinoma
Liu, J., Huo, J., Zhang, Z., Xiao, X., Li, S., Wu, Y., Chen, W., Chen, Z., Zheng, C., Liu, M., et al. (2025) · BMC Biotechnology · doi:10.1186/s12896-025-01045-6 · Cited by 3
Microbiome and cancer: mechanistic insights, diagnostic potential, and therapeutic strategies
Kumar, V., Chaudhary, A., Gautam, M., Verma, P., & Singh, M. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1844436 · Cited by 3
Effect of microbial dysbiosis on autoimmune associated inflammation
Singh, K., & Bhadauriya, A. S. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2024.12.016 · Cited by 3
The role of bacteria in the treatment of cancer: A comprehensive review
Khadem, E., Nafari, A., Safarzadeh, A., Jozaei, R. F., Almasian, M., & Elyasi, H. (2020) · Plant Biotechnology Persa · doi:10.29252/pbp.2.1.26 · Cited by 3
Akinduti, P. A., Izevbigie, O. O., Akinduti, O. A., Enwose, E. O., & Amoo, E. O. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae106 · Cited by 3
Regulation of Host Chromatin by Bacterial Metabolites
Mani, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802389-1.00023-x · Cited by 3
The Prevalence of Polyketide Synthase-Positive E. coli in Cystic Fibrosis
Chan, C., Coffey, M. J., Murphy, C., McKay, I. R., Abdu, J., Paida, K., Tam, R. Y., Wrigley-Carr, H., Prentice, B. J., Owens, L., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13030681 · Cited by 2
Barrack, K. E., Surve, S. V., Bezerra, A. K. S., Murphy, C. E., Soucy, S. M., Ramos, M. A. A., Valls, R. A., Ruff, R. D., Balskus, E. P., Sanville, J. L., et al. (2026) · Journal of Bacteriology · doi:10.1128/jb.00190-26 · Cited by 2
Prabhakaran, R., Muthu, R., Rajkumar, M., Subramanian, V., & Mahendran, K. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1736094 · Cited by 2
Ahn, J. A. O. K., Hazelton, A., Nguyen, J., & Arthur, J. C. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01725-z · Cited by 2
Zhou, Q., & Meng, Q. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-58311-7_6 · Cited by 3
A history of exploring cancer in context
Maman, S., & Witz, I. P. (2018) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0024-x · Cited by 2
Fatemi, N., Jahdkaran, M., Mirbahari, S. N., & Houri, H. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2024.31 · Cited by 2
Cancer research driven by cutting-edge multi-disciplinary technologies
Lyu, Q., Feng, Y., Shi, R., Wu, J., & Han, W. (2020) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2020-0638 · Cited by 2
The Microbiome in Gastrointestinal Cancers
White, M. G., & Wargo, J. A. (2022) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2022.06.007 · Cited by 2
Genomic Islands in Klebsiella pneumoniae
Shukla, S., Joshi, P., Trivedi, P., Akinwotu, O. O., & Gajjar, D. U. (2023) · Springer eBooks · doi:10.1007/978-981-19-9342-8_13 · Cited by 2
Geervliet, M. (2021) · doi:10.18174/553257 · Cited by 2
El‐Daly, S. M., Fayed, B. E., Talaat, R. M., Gouhar, S. A., Fahmy, C. A., El-Jawad, A. M. A., Hamdy, N. Μ., & Elmageed, Z. Y. A. (2026) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-032-08530-6_2 · Cited by 1
Non-coding RNAs participate in interactions between senescence and gastrointestinal cancers
Liu, Z., Ji, F.-H., & Piao, Y. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2024.1461404 · Cited by 1
Yi, L., Mo, A., Yang, H., Yang, Y., Xu, Q., & Yuan, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1475195 · Cited by 1
Mir, R., Albarqi, S., Albalawi, W., Alanazi, G. B., Alsubaie, S. S., Alghaban, R. I., Alanazi, H. S., Alenazi, M. F., Albogmi, A., Alzahrani, O. R., et al. (2025) · Discovery Medicine · doi:10.24976/discov.med.202537198.105 · Cited by 1
Pacheco-Barcía, V., Méndez, A. M., Hernández-Jiménez, E., Jiménez‐Fonseca, P., Martín, A. J. M., Custodio‐Cabello, S., Palka-Kotlowska, M., Gonzalez-Diaz, I., & Cabezón‐Gutiérrez, L. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i10.107877 · Cited by 1
Yuwei, Z. H. A. O., Tong, Z., Liu, L., Yang, R., Chen, Z., & Wang, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1675448 · Cited by 1
Chen, B., Gg, C., Leng, X., Li, Q., Wu, W., Wu, W., Liu, Z., Zhong, Z., Zheng, X., Kang, W., et al. (2026) · Advanced Science · doi:10.1002/advs.202519949 · Cited by 2
Chen, J., Zhao, J., Zhang, X., & Zhu, H. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1768252 · Cited by 1
Theodoropoulos, G. E. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-59642-2_4 · Cited by 1
Microbiota and Chronic Inflammation as Targets for Colorectal Cancer Prevention
Ciliberto, D., Fiorillo, L., Iuliano, E., Giudice, T. D., & Tagliaferri, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-31254-5_2 · Cited by 1
Canine Genetics, Health and Medicine
Rutland, C. S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.92513 · Cited by 1
Gut Microbiome in Health and Gastrointestinal Cancer
Lau, H. C.-H. (2023) · Springer eBooks · doi:10.1007/978-981-19-4492-5_2 · Cited by 1
Azour, A., Al-Bayssari, C., & Rolain, J. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4863297 · Cited by 1
Proaño-Vasco, A., Obwegs, D., Bruder, K., Ritzkowski, C., Eichner, S., Houle, L., Sun, Y., Tanes, C., Klaas, L., Schömig, L. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.10.687579 · Cited by 1
Microbiota and Colon Cancer: Orchestrating Neoplasia Through DNA Damage and Immune Dysregulation
Martín, A., & Irrazábal, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65124-3
ANTI-INFLAMMATORY EFFECTS OF POLYPHENOL-ENRICHED EXTRACTS AND THEIR GUT MICROBIAL METABOLITES
DaSilva, N. A. (2019) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-dasilva-nicholas-2019
Arora, R., Hermann, A., & Wargo, J. A. (2019) · Springer eBooks · doi:10.1007/978-1-4614-7322-0_41-1
Nutrition, the Gastrointestinal Microbiota and Cancer Prevention
Lopes, R. G., do Prado, S. B. R., & Fabi, J. P. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016506-00261
Maisonneuve, C. (2019) · TSpace (University of Toronto)
Irrazábal, T. (2018) · TSpace (University of Toronto)
Arora, R., Hermann, A., & Wargo, J. A. (2019) · Springer eBooks · doi:10.1007/978-1-4614-7147-9_41
Correlation Between Colorectal Cancer, Intestinal Flora and miRNA
(2022) · Journal of Contemporary Medical Practice · doi:10.53469/jcmp.2022.04(05).24
Gut Microbiota and Host Immune System in Cancer
Sunita, P., Pattanayak, S. P., Ranjan, G., & Bose, P. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815124781123030004
The microbiome and cancer immunotherapy
Niederhuber, J. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87763-3.00020-4
MicroRNA-microbiota interaction regulates host lipid metabolism
Hu, H. T., Fang, H., Deng, Z., Zhou, X., & Yin, Y. (2023) · Scientia Sinica Vitae · doi:10.1360/ssv-2023-0056
How the Microbiome Affects the Risk for Colon Cancer
Drewes, J. L., & Bhatt, A. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-46712-7_7
The Relationship between Gut Microbiota and Thyroid Cancer
王, 浩. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.151004
Amiriani, T., Khasheii, B., Zamani, S., Ghelichi-Ghojogh, M., & Jamalli, A. (2025) · Motaleat-e Tatbiqi-e Honar · doi:10.61186/jommid.13.1.39
Gut-Brain Axis and Colorectal Cancer: Neuroimmune Interactions
Prasad, A., Acharya, S., Singh, A., Raj, U., & Sharma, A. (2025) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-031-86065-2_12
Cancer Association with Bacterial Biofilm
Vignesh, K., Bavyataa, V., Sri, K. D., Balasubramani, R., Mariappan, V., & Moorthi, P. V. (2025) · Springer eBooks · doi:10.1007/978-981-96-8975-0_13
Influence of bacterial proteins on the host’s cell cycle
Benedetti, F., Summers, C., Gallo, R. C., & Zella, D. (2025) · Cell Cycle · doi:10.1080/15384101.2025.2577757
Malakar, S., Kumar, Y., Sutaoney, P., & Shahadat, M. (2026) · Gene Reports · doi:10.1016/j.genrep.2026.102442
de Lima, S. H. A., Albulquerque, A. S., Bruno, C. E. M., de Castro, S. O., de Souza, G. C., Macagnan, E., de Castilho, P. V., Weber, M. G., & Moreira, J. R. (2026) · Brazilian Journal of Animal and Environmental Research · doi:10.34188/bjaerv9n1-091
Deciphering in vivo efficacy of virulent phages in the mammalian gut
Lourenço, M. (2019) · theses.fr (ABES) · doi:10.70675/c305c7b8z2178z4a27z839fzc54f45a70648
Rôle de l'îlot génomique pks dans la synthèse des sidérophores-microcines chez Escherichia coli
Massip, C. (2019) · theses.fr (ABES) · doi:10.70675/79fd3cdcz6be0z491ez95c5zf2b155b65e97
The Microbiome and Cancer: Exploring the Gut Connection
Om, H., Reshamwala, S. M. S., & Devarajan, P. V. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814113126010010
Azour, A., Matar, G. M., & Bilen, M. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1842853
Jia, R., Martin, L. A., Saraiva, M., Sifré, E., Varon, C., Dubus, P. R., & Ménard, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.01.729203
Zhang, Y., Yu, X., Li, S., Chen, Q., & Wang, H. Y. (2026) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-026-00372-9
Lee, S. Y., Cho, S., & Song, J. (2026) · Nutrients · doi:10.3390/nu18121909
He, Y., 李廷慧, Sun, H., & Yang, J. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-05023-0
Virulome over taxonomy: refining the driver-passenger model in colorectal carcinogenesis
Glazunova, E. V., Kurnosov, A., Bogacheva, A., Makarov, V., & Zlobovskaya, O. A. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1858868
Tataka, Y., Kawashima, H., Nanri, H., Watanabe, D., Watanabe, K., Yamaguchi, M., Kunisawa, J., & Miyachi, M. (2026) · BMC Microbiology · doi:10.1186/s12866-026-05460-3
Genome and piliome analysis of E. coli isolates from human colorectal cancer biopsies
Kolata, M., Dhondt, A., Gerven, N. V., Sleutel, M., Gräf, C., Verbandt, S., Tejpar, S., & Remaut, H. K. (2026) · BMC Microbiology · doi:10.1186/s12866-026-05515-5
Sarkar, P., Shannigrahi, S., Sen, O., Adak, S., Jana, P., & Manna, S. (2026) · ChemistrySelect · doi:10.1002/slct.202507043
Shi, M., Zeng, Y., Chen, C., & Zuo, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1951036
Missaoui, N. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1017577
Systemic antibody repertoires target specific microbial antigens in patients with colorectal cancerPreprint
Innocenti, G., Brezina, S., Barozzi, I., Prinzensteiner, M., Reyna-Blanco, C. S., Kołek, M. F., Prosenz, J., Maieron, A., Gsur, A., & Vogl, T. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.15.759395
Metadata
- Authors
- Dalmasso, G., Cougnoux, A., Delmas, J., Darfeuille-Michaud, A., & Bonnet, R.
- Affiliations
- Inserm (FR)
- Corresponding author
- Bonnet, Richard
- Venue
- Gut Microbes
- Publisher
- Informa UK Limited
- Published
- 2014-09-03
- Volume
- 5
- Issue
- 5
- Pages
- 675-680
- ISSN
- 1949-0976 (ISSN-L)
- 1949-0984
- PMC
- PMC4615906
- OpenAlex
- W1964485249
- Semantic Scholar
- 10b0e7d77ac0c96917fb9e7be28852f987ee6021
- Cited by
- 296
- References
- 30
- Citations by year
- 2026: 22 · 2025: 32 · 2024: 27 · 2023: 31 · 2022: 35 · 2021: 39 · 2020: 35 · 2019: 24 · 2018: 18 · 2017: 16 · 2016: 11 · 2015: 5
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gut Microbes (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- Institut National de la Santé et de la Recherche Médicale (USC-2018, U1071)
- Ligue Contre le Cancer
- Centre National de la Recherche Scientifique
- Institut National de la Recherche Agronomique (U1071, USC-2018)
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- colibactin, Escherichia coli, colorectal cancer, tumor microenvironment, cellular senescence, SENP1, miR-20a-5p, growth factors, gut microbiota, carcinogenesis, xenograft mouse model
- MeSH terms
- Animals, Colonic Neoplasms, Cysteine Endopeptidases, Escherichia coli, Models, Biological, Mutagens, Endopeptidases, Peptides, Tumor Suppressor Protein p53, MicroRNAs, Mice, Sumoylation, Tumor Microenvironment, Polyketides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
